Download PDF
Thromb Haemost 1975; 34(02): 419-425
DOI: 10.1055/s-0038-1651401
Original Article
Schattauer GmbH

Oral Anticoagulant Therapy and its Control: An International Survey

P. R. L. C Lam-Po-Tang   *
,
L Poller
1   Prince of Wales Hospital, Randwick, N.S.W., Australia and the World Health Organisation Collaborating Centre for Anticoagulant Control Reagents, Withington Hospital, Manchester, M 20 8LR
› Author Affiliations
Further Information

Publication History

Received 20 February 1975

Accepted 22 June 1975

Publication Date:
24 July 2018 (online)

    Permissions and Reprints

Summary

A survey for the International Study Group for Anticoagulant Control has been conducted in which a questionnaire was sent to members in 39 countries. Information based on 37 replies obtained indicated that the most widely used test in oral anticoagulant therapy is the Quick one stage prothrombin estimation. There is a great diversity in the method of reporting prothrombin time results. Percentage activity of normal on the basis of saline dilution curves is the most popular. Only six countries have national or regional systems for anticoagulant control.

Recommendations for the therapeutic range of dosage vary widely. The upper limit in one country may be the lower limit in another. In many centres doses of anticoagulant drugs are advocated which elsewhere are considered either inadequate anticoagulation or dangerous overdosage. The variation of therapeutic range may still be considerable even when a standard thromboplastin is available.

Data collected from the survey indicates the need for urgent measures to provide a uniform basis of laboratory control of clinical dosage of anticoagulant drugs. Until such measures are implemented it is meaningless to try to compare the efficacy of oral anticoagulant therapy from country to country or even to attempt multicentre trials within national boundaries.

* Secretary, International Study Group for Anticoagulant Control.


 

  • References

  • 1 Biggs R, and Denson K. W. E. 1967; Standardisation of the one-stage prothrombin time for the control of anticoagulant therapy. British Medical Journal I: 84.
    PubMedGoogle Scholar
  • 2 Owren P. A. 1959; Thrombotest: - A new method for controlling anticoagulant therapy. Lancet II: 754.
    PubMedGoogle Scholar
  • 3 Owren P. A, and Aas K. 1951; The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scandinavian Journal of Clinical and Laboratory Investigation 3: 201.
    CrossrefPubMedGoogle Scholar
  • 4 Poller L. 1964; Standardisation of anticoagulant treatment: The Manchester regional thromboplastin scheme. British Medical Journal II: 565.
    PubMedGoogle Scholar
  • 5 Sevitt S. 1970. In: Hulmb M, Sevitt S, and Thomas D. P. (eds.) Venous thrombosis and pulmonary embolism. Harvard; Massachusetts: 398.
    Google Scholar